• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异时性对侧成熟卵巢畸胎瘤的患病率:一项系统评价。

Prevalence of metachronous contralateral mature ovarian teratoma: A systematic review.

作者信息

Kiely David, Lewis Carianne, Gray Juliet, Hall Nigel

机构信息

Department of Paediatric Surgery and Urology, Queens Medical Centre, Nottingham, UK.

Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK.

出版信息

Pediatr Blood Cancer. 2021 Nov;68(11):e29237. doi: 10.1002/pbc.29237. Epub 2021 Jul 31.

DOI:10.1002/pbc.29237
PMID:34331503
Abstract

There is increasing recognition that contralateral metachronous tumor may occur following treatment of unilateral mature ovarian teratoma. We aimed to define this risk to guide appropriate surveillance strategies. We undertook a systematic review of three large medical databases (Ovid Medline, Embase, and Cochrane Controlled Trials Register) to April 2020 using a defined search strategy. From 1831 articles retrieved, 23 were included, reporting 1101 girls with unilateral mature ovarian teratomas. The intensity and duration of follow-up varied between studies, with only five reporting close surveillance. Overall prevalence of metachronous contralateral mature teratoma was 2.1%, with a prevalence per study of 0%-23% (median 0%). Prevalence was higher (7%) among studies with more robust surveillance. These data suggest a small but real risk of metachronous contralateral tumors. Surveillance ultrasonography is proportionate and indicated alongside further prospective data collection to record the natural history and impact of surveillance in greater detail.

摘要

越来越多的人认识到,单侧成熟卵巢畸胎瘤治疗后可能会发生对侧异时性肿瘤。我们旨在明确这种风险,以指导适当的监测策略。我们使用既定的检索策略,对截至2020年4月的三个大型医学数据库(Ovid Medline、Embase和Cochrane对照试验注册库)进行了系统评价。从检索到的1831篇文章中,纳入了23篇,报道了1101例患有单侧成熟卵巢畸胎瘤的女孩。各研究之间随访的强度和持续时间各不相同,只有5项研究报告了密切监测。异时性对侧成熟畸胎瘤的总体患病率为2.1%,每项研究的患病率为0%-23%(中位数为0%)。在监测更完善的研究中,患病率更高(7%)。这些数据表明,异时性对侧肿瘤存在虽小但实际的风险。监测超声检查是合理的,同时还需要进一步进行前瞻性数据收集,以更详细地记录自然病史和监测的影响。

相似文献

1
Prevalence of metachronous contralateral mature ovarian teratoma: A systematic review.异时性对侧成熟卵巢畸胎瘤的患病率:一项系统评价。
Pediatr Blood Cancer. 2021 Nov;68(11):e29237. doi: 10.1002/pbc.29237. Epub 2021 Jul 31.
2
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.
3
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
5
Treatment options for progression or recurrence of glioblastoma: a network meta-analysis.治疗胶质母细胞瘤进展或复发的选择:网络荟萃分析。
Cochrane Database Syst Rev. 2021 May 4;5(1):CD013579. doi: 10.1002/14651858.CD013579.pub2.
6
Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).针对接受体外受精加卵胞浆内单精子注射(IVF/ICSI)的女性,使用卵巢储备标志物进行个性化促性腺激素剂量选择。
Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD012693. doi: 10.1002/14651858.CD012693.pub2.
7
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
8
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.
9
Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.对携带BRCA1或BRCA2基因突变的女性进行降低风险的双侧输卵管卵巢切除术。
Cochrane Database Syst Rev. 2018 Aug 24;8(8):CD012464. doi: 10.1002/14651858.CD012464.pub2.
10
Interventions for fertility preservation in women with cancer undergoing chemotherapy.对接受化疗的癌症女性进行生育力保存的干预措施。
Cochrane Database Syst Rev. 2025 Jun 19;6:CD012891. doi: 10.1002/14651858.CD012891.pub2.

引用本文的文献

1
Prognosis and postoperative surveillance of benign ovarian tumors in children: a single-center retrospective study.儿童卵巢良性肿瘤的预后及术后监测:一项单中心回顾性研究
J Pediatr (Rio J). 2025 Jul-Aug;101(4):595-600. doi: 10.1016/j.jped.2025.03.009. Epub 2025 May 10.
2
Giant Mature Ovarian Cystic Teratoma in a Pediatric Patient: Case Report and Literature Review.一名儿科患者的巨大成熟性卵巢囊性畸胎瘤:病例报告与文献综述
Case Rep Oncol. 2023 Oct 6;16(1):1066-1072. doi: 10.1159/000534141. eCollection 2023 Jan-Dec.
3
Immature Teratoma: Diagnosis and Management-A Review of the Literature.
未成熟畸胎瘤:诊断与管理——文献综述
Diagnostics (Basel). 2023 Apr 23;13(9):1516. doi: 10.3390/diagnostics13091516.